Page last updated: 2024-08-21

levonorgestrel and dutasteride

levonorgestrel has been researched along with dutasteride in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andricopulo, AD; Moda, TL; Montanari, CA	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Amory, JK; Berger, R; Bremner, WJ; Matthiesson, KL; McLachlan, RI; Meachem, SJ; O'Donnell, L; Stanton, PG	1
Dinger, ME; Laven-Law, G; Matthiesson, KL; McCabe, MJ; McLachlan, RI; Meachem, SJ; Stanton, PG; Tarulli, GA	1

Reviews

1 review(s) available for levonorgestrel and dutasteride

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for levonorgestrel and dutasteride

Article	Year
Effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men. The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:10 Topics: 5-alpha Reductase Inhibitors; Adult; Androstanes; Azasteroids; Dihydrotestosterone; Dutasteride; Enzyme Inhibitors; Estradiol; Germ Cells; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Male; Progesterone Congeners; Prospective Studies; Sertoli Cells; Spermatogenesis; Steroids; Testis; Testosterone; Vasectomy	2005
Gonadotropin suppression in men leads to a reduction in claudin-11 at the Sertoli cell tight junction. Human reproduction (Oxford, England), 2016, Volume: 31, Issue:4 Topics: 5-alpha Reductase Inhibitors; Adult; Androgens; Blood-Testis Barrier; Claudins; Contraceptive Agents, Male; Down-Regulation; Dutasteride; Gonadotropin-Releasing Hormone; Humans; Immunohistochemistry; Levonorgestrel; Male; Middle Aged; Oligopeptides; Protein Transport; Reproducibility of Results; Sertoli Cells; Spermatogenesis; Testosterone; Tight Junctions; Young Adult	2016

Article

Year

Effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men.

The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:10

Topics: 5-alpha Reductase Inhibitors; Adult; Androstanes; Azasteroids; Dihydrotestosterone; Dutasteride; Enzyme Inhibitors; Estradiol; Germ Cells; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Male; Progesterone Congeners; Prospective Studies; Sertoli Cells; Spermatogenesis; Steroids; Testis; Testosterone; Vasectomy

2005

Gonadotropin suppression in men leads to a reduction in claudin-11 at the Sertoli cell tight junction.

Human reproduction (Oxford, England), 2016, Volume: 31, Issue:4

Topics: 5-alpha Reductase Inhibitors; Adult; Androgens; Blood-Testis Barrier; Claudins; Contraceptive Agents, Male; Down-Regulation; Dutasteride; Gonadotropin-Releasing Hormone; Humans; Immunohistochemistry; Levonorgestrel; Male; Middle Aged; Oligopeptides; Protein Transport; Reproducibility of Results; Sertoli Cells; Spermatogenesis; Testosterone; Tight Junctions; Young Adult

2016

Other Studies

2 other study(ies) available for levonorgestrel and dutasteride

Article	Year
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013

Article

Year

Hologram QSAR model for the prediction of human oral bioavailability.

Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013